Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

1.840 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
PacBio (PACB) Q4 2025 Earnings Call Transcript ↗
PacBio (PACB) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB) Beats Q4 2025 Revenue and EPS Estimates ↗
Via Chartmill
News headline image
PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 13.8% year on year to $44.65 million. Its non-GAAP... 
Via StockStory
News headline image
PacBio Earnings: What To Look For From PACB
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday after market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
3 Cash-Burning Stocks We Approach with Caution
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to... 
Via StockStory
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
3 Stocks Under $10 with Warning Signs
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as... 
Via StockStory
Topics Electric Vehicles
News headline image
3 Unpopular Stocks That Concern Us
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
Via StockStory
News headline image
3 Reasons to Sell PACB and 1 Stock to Buy Instead
PacBio’s 38.9% return over the past six months has outpaced the S&P 500 by 28.4%, and its stock price has climbed to $2.06 per share. This performance may have investors wondering how to approach the... 
Via StockStory
Topics Stocks
News headline image
3 Unprofitable Stocks That Concern Us
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
News headline image
PacBio (PACB) Stock Is Up, What You Need To Know
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2.9% in the morning session after news from a previous session revealed that Cathie Wood's investment firm, ARK Invest,... 
Via StockStory
Topics Artificial Intelligence
News headline image
Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24
Check out the companies making headlines this week: 
Via StockStory
News headline image
Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio
Check out the companies making headlines yesterday: 
Via StockStory
News headline image
Why Is PacBio (PACB) Stock Soaring Today
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 6.1% in the afternoon session after Cathie Wood's investment firm, ARK Invest, purchased a substantial number of its... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
2 Russell 2000 Stocks Worth Investigating and 1 Facing Challenges
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
News headline image
3 Stocks Under $10 with Open Questions
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be... 
Via StockStory
News headline image
Why PacBio (PACB) Stock Is Up Today
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 4.5% in the afternoon session after the stock's positive momentum continued as the company announced advances in its... 
Via StockStory
Topics Artificial Intelligence
News headline image
popEVE AI: Harvard-Developed Model Set to Revolutionize Rare Disease Diagnosis and Drug Discovery
Cambridge, MA & Barcelona, Spain – November 25, 2025 – A groundbreaking artificial intelligence model, popEVE, developed by a collaborative team of researchers from Harvard Medical School and the... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a Politico report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. The proposal would extend subsidies... 
Via StockStory
Topics Economy
News headline image
Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
3 of Wall Street’s Favorite Stocks We Approach with Caution
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Topics Retirement
News headline image
Why PacBio (PACB) Shares Are Getting Obliterated Today
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) fell 7.5% in the afternoon session after the market continued to react negatively to the company's third-quarter financial... 
Via StockStory
News headline image
Stocks making big moves yesterday: Bumble, Five Below, PacBio, ON24, and Yum China
Check out the companies making headlines yesterday: 
Via StockStory
News headline image
5 Revealing Analyst Questions From PacBio’s Q3 Earnings Call
PacBio’s third quarter was met with a significant negative market reaction, reflecting disappointment over revenue that fell short of Wall Street expectations. Management attributed the... 
Via StockStory
Topics Earnings
News headline image
Why PacBio (PACB) Stock Is Up Today
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2.8% in the afternoon session after an analyst at Stephens & Co. raised the price target on the stock while maintaining... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at PacBio (NASDAQ:PACB) and the best and worst... 
Via StockStory
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus
Genomics company Pacific Biosciences of California (NASDAQ:PACB) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 3.8% year on year to $38.44 million. Its non-GAAP loss of... 
Via StockStory
News headline image
PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings
Genomics company Pacific Biosciences of California (NASDAQ:PACB) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 3.8% year on year to $38.44 million. Its non-GAAP loss... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.